# Gateflow Draft PR Pass — Sell Put Top1 W4

## Gate

- Work unit: `sell-put-top1-w4`
- Gate: `draft-PR-pass`
- Date: `2026-08-15`
- Draft PR: `https://github.com/liuxie066/options-monitor/pull/162`
- Current base: `main@baa68162`
- Accepted PR-review head: `fdcda279`
- PR review: `docs/reviews/pr-162-review-20260815-150932.md`
- State at review: `OPEN`, `DRAFT`, `MERGEABLE`

## Entry criteria

- [x] W4 remains limited to Corpus preparation; it does not run 40-day research or 20-day hidden validation.
- [x] S1, S2, aggregate, and PR-level Kimi DeepReviews have zero unresolved findings.
- [x] Focused plus adjacent suites passed: `120 passed`.
- [x] Aggregate full suite passed: `4892 passed, 10 skipped`.
- [x] Ruff, BasedPyright error level, architecture guard, dependency graph, and `git diff --check` passed.
- [x] Agent Plugin, Guardrails, CodeQL Actions, CodeQL Python, and CodeQL summary passed on `fdcda279`.
- [x] PR base/head matched the reviewed range with no drift.

## Residual risks and owners

- Calendar, maturity, and provider truth remain caller-owned evidence and later-work-unit responsibility.
- Real 40-day research is W5; independent 20-day hidden validation is W6; timer/CLI/Agent/provider integration is W7.
- Content-addressed orphan cleanup and multi-process integration testing remain deferred until runtime evidence justifies them.

## Safety boundary

No release, deployment, service/configuration change, provider call, runtime Corpus write, real experiment, notification, market-data read, ledger write, or broker action was performed.

## Conclusion

`draft-PR-pass`.

Current gate / next entry point: commit this evidence, wait for final CI, then record W4 final closeout. Merge remains a separate authorization boundary.
